MedTrace Logo

Impact Of RA Therapy Compliance On Patient-Reported Outcomes

NCT01438892 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 396

Last updated 2013-04-08

No results posted yet for this study

Summary

Several observational studies have evaluated the comparative treatment costs associated with each agent, particularly those within the anti-TNF class, but few have evaluated the impact of therapy compliance, persistence, treatment patterns on patient reported outcomes, healthcare utilization and costs, using a provider database. This study is designed to fill in this information gap.

Conditions

Interventions

DRUG

tDMARDs

Traditional DMARDs for RA

DRUG

biodmards

Biologic DMARDs

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-01-31
Completion
2013-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01438892 on ClinicalTrials.gov